97 related articles for article (PubMed ID: 23396994)
1. Brain amyloid imaging.
Rowe CC; Villemagne VL
J Nucl Med Technol; 2013 Mar; 41(1):11-8. PubMed ID: 23396994
[TBL] [Abstract][Full Text] [Related]
2. Brain amyloid imaging.
Rowe CC; Villemagne VL
J Nucl Med; 2011 Nov; 52(11):1733-40. PubMed ID: 21917849
[TBL] [Abstract][Full Text] [Related]
3. Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir.
Trembath L; Newell M; Devous MD
J Nucl Med Technol; 2015 Sep; 43(3):175-84. PubMed ID: 26271806
[TBL] [Abstract][Full Text] [Related]
4. Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?
Dubroff JG; Nasrallah IM
Acad Radiol; 2015 Aug; 22(8):988-94. PubMed ID: 26100192
[TBL] [Abstract][Full Text] [Related]
5. Novel indanone derivatives as potential imaging probes for β-amyloid plaques in the brain.
Qiao JP; Gan CS; Wang CW; Ge JF; Nan DD; Pan J; Zhou JN
Chembiochem; 2012 Jul; 13(11):1652-62. PubMed ID: 22777884
[TBL] [Abstract][Full Text] [Related]
6. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains.
Ono M; Cheng Y; Kimura H; Cui M; Kagawa S; Nishii R; Saji H
J Med Chem; 2011 Apr; 54(8):2971-9. PubMed ID: 21428407
[TBL] [Abstract][Full Text] [Related]
7. Nuclear medicine imaging in dementia: a practical overview for hospitalists.
Toney LK; McCue TJ; Minoshima S; Lewis DH
Hosp Pract (1995); 2011 Aug; 39(3):149-60. PubMed ID: 21881402
[TBL] [Abstract][Full Text] [Related]
8. Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.
Vanitallie TB
Metabolism; 2013 Jan; 62 Suppl 1():S30-3. PubMed ID: 23021038
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer disease and other dementias.
Odle TG
Radiol Technol; 2003; 75(2):111-35; quiz 136-9. PubMed ID: 14671829
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
[TBL] [Abstract][Full Text] [Related]
11. Amyloid imaging in Alzheimer's disease.
Nordberg A
Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
13. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
14. The molecular pathology of Alzheimer's disease.
Harrington CR
Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
[TBL] [Abstract][Full Text] [Related]
15. Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients.
Gulyás B; Spenger C; Beliczai Z; Gulya K; Kása P; Jahan M; Jia Z; Weber U; Pfeifer A; Muhs A; Willbold D; Halldin C
Neurochem Int; 2012 Jan; 60(2):153-62. PubMed ID: 22100791
[TBL] [Abstract][Full Text] [Related]
16. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-plaque imaging in early and differential diagnosis of dementia.
Drzezga A
Ann Nucl Med; 2010 Feb; 24(2):55-66. PubMed ID: 20082230
[TBL] [Abstract][Full Text] [Related]
18. Biochemical assay for amyloid beta deposits to distinguish Alzheimer's disease from other dementias.
Kaplan B; Haroutunian V; Koudinov A; Patael Y; Pras M; Gallo G
Clin Chim Acta; 1999 Feb; 280(1-2):147-59. PubMed ID: 10090532
[TBL] [Abstract][Full Text] [Related]
19. Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction.
van Norden AG; van Dijk EJ; de Laat KF; Scheltens P; Olderikkert MG; de Leeuw FE
Biochim Biophys Acta; 2012 Mar; 1822(3):340-9. PubMed ID: 21777675
[TBL] [Abstract][Full Text] [Related]
20. β-Amyloidosis and neurodegeneration in Alzheimer disease: who's on first?
Knopman DS
Neurology; 2014 May; 82(20):1756-7. PubMed ID: 24748669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
